---
title: "Bio-Techne Corp. Stock Outperforms Competitors On Strong Trading Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281425482.md"
description: "Bio-Techne Corp. (TECH) shares rose 2.33% to $53.48 on a strong trading day, outperforming competitors like Amgen Inc. and Charles River Laboratories. This marks the third consecutive day of gains for Bio-Techne, although it remains 25.89% below its 52-week high of $72.16. The S&P 500 Index and Dow Jones Industrial Average also saw increases of 0.72% and 0.48%, respectively, with trading volume surpassing its 50-day average."
datetime: "2026-04-01T21:18:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281425482.md)
  - [en](https://longbridge.com/en/news/281425482.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281425482.md)
---

# Bio-Techne Corp. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Bio-Techne Corp. (TECH) rose 2.33% to $53.48 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.72% to 6,575.32 and the Dow Jones Industrial Average rising 0.48% to 46,565.74.

This was the stock's third consecutive day of gains.

Bio-Techne Corp. closed 25.89% below its 52-week high of $72.16, which the company reached on January 22nd.

The stock outperformed some of its competitors Wednesday, as Amgen Inc. (AMGN) rose 0.41% to $353.28, Charles River Laboratories International Inc. (CRL) rose 1.39% to $174.90, and BioMarin Pharmaceutical Inc. (BMRN) rose 1.33% to $57.24.

Trading volume (2.5 M) eclipsed its 50-day average volume of 2.4 M.

Data source: Dow Jones Market Data, FactSet. Data compiled April 1, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

04-01-26 1718ET

### Related Stocks

- [TECH.US](https://longbridge.com/en/quote/TECH.US.md)

## Related News & Research

- [4Moving Biotech Granted FDA Fast Track Designation to 4P004, Supporting an Accelerated Development Pathway in Knee Osteoarthritis](https://longbridge.com/en/news/283601589.md)
- [Bio-Techne Corp. Stock Underperforms Wednesday When Compared To Competitors](https://longbridge.com/en/news/284646666.md)
- [Fagan Associates Inc. Acquires 24,910 Shares of Netflix, Inc. $NFLX](https://longbridge.com/en/news/284527634.md)
- [Dara Capital US Inc. Invests $6.26 Million in Alphabet Inc. $GOOGL](https://longbridge.com/en/news/284075078.md)
- [Bio-Techne Corp. Stock Outperforms Competitors On Strong Trading Day](https://longbridge.com/en/news/269292701.md)